News
Heston Blumenthal is using weight-loss injections, despite his concerns that they could devastate the restaurant trade. The ...
"The world needs to move on from outdated and archaic misinterpretations of perceived difference, and embrace the ...
Novo Nordisk A/S (NYSE:NVO) ranks among the best medical stocks to buy according to analysts. On July 18, Deutsche Bank ...
3hon MSN
Heston Blumenthal says weight-loss drugs are ruining restaurants - even though he takes them himself
Celebrity chef Heston Blumenthal says weight-loss drugs are killing restaurants - despite taking them himself.
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...
HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% ...
Some obese Americans on Medicare and Medicaid could get access to expensive weight loss drugs under a five-year experiment ...
Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
A move to offer costly weight-loss drugs for obese Americans on Medicare and Medicaid may be in the works, but such a program ...
Shares of Novo Nordisk ( NVO 2.48%) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results